UNSPSC 51433506: Amiquinsin hydrochloride

This classification denotes an antihypertensive agent with the molecular formula C11H12N2O2.ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EZ270U8Z9W, chemically known as 4-quinolinamine, 6,7-dimethoxy-, monohydrochloride, monohydrate but more generally known as amiquinsin hydrochloride, which bears US NIH Compound Identifier 23509. Most nations, for tariff and trade purposes, schedule amiquinsin hydrochloride under HS 29334990 and SITC 51575.

As of Q4 2014, AMIQUINSIN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Amiquinsin hydrochloride bears US NLM identifiers UMLS ID C0953995 and NCI Concept Code C75237. SMILES: COC1CC2C(CCNC2CC1OC)N.O.CL.

UNSPSC 51433506 Amiquinsin hydrochloride is a Commodity code that covers pharmaceutical preparations used in emergency medical care. State and local governments procure advanced life support medications under this code — specifically injectable drugs used by fire rescue and emergency medical services (EMS) to treat acute cardiac and respiratory conditions. The City of Tampa's Purchasing Department issued an IFB (Invitation for Bid) in April 2026 for Advanced Life Support Medications to be supplied to Tampa Fire Rescue, requiring vendors to furnish Labetalol HCI, Epinephrine, Adenosine, and Diltiazem in specified unit counts. Issuing bodies for medications in this category are primarily municipal fire and EMS departments and their procurement offices, which source drugs through competitive sealed-bid processes to ensure cost control and supply reliability for emergency response operations. Medications must meet strict expiration, quality, and safety standards — including minimum 365-day defect warranties, nine-month minimum shelf life at delivery, and OSHA-compliant Safety Data Sheets — and vendors typically manage replacement and pickup of expired stock during the contract term.

The Tampa solicitation, posted April 24, 2026, with a bid deadline of April 8, 2026, represents one of the few recent state and local opportunities visible under this specific commodity code. The contract was estimated at $40,000.00 and included a Small Local Business Enterprise sheltered-market set-aside with a five percent bid discount (not to exceed $10,000), along with mandatory accessibility and federal Section 508 compliance documentation. The contract term ran one year from award with two optional one-year renewals plus three unilateral 30-day extensions. No other recent opportunities under UNSPSC 51433506 appear in the available record, suggesting limited solicitation activity under this specific pharmaceutical commodity; fire rescue and EMS procurement in Florida and other states may consolidate purchases under broader advanced-life-support or emergency-medication family codes rather than at this detailed commodity level.